Mindfulness-based Intervention for Postnatal Depression

March 30, 2020 updated by: Dr. Jingxia Lin, The University of Hong Kong

The Impacts of Mindfulness-based Intervention on Symptoms and Cognition in Chinese Women With Postnatal Depressive Symptoms - A Randomized Controlled Clinical Trial

Postnatal psychopathology have adverse impact on both mothers and infants. Few postnatal women with depressive symptoms receive treatment, and pharmacological intervention has not been well accepted due to the medication side-effects. Recently, mindfulness-based interventions were found to be beneficial for symptoms in perinatal and antenatal women with depression. These non-pharmacological interventions require less resources and are more feasible for postnatal women to practice at home. To date, no randomized controlled trial has examined mindfulness-based intervention program as a treatment for women with postnatal depression. The proposed randomized controlled trial aims to examine the effects of an 8-week mindfulness-based intervention program on symptom and cognition for postnatal females with depressive symptoms.

A total of 70 postnatal women with depressive symptoms will be recruited from the psychiatric outpatient clinics in Hong Kong, and will be randomized into two groups: 1) an 8-week mindfulness-based intervention program (n=35); 2) a booklet-based psychoeducation control group (n=35). All participants will be assessed for depression, anxiety, stress, cognition, role functioning, quality of life, sleep quality and mindfulness ability at the baseline, 8 weeks, and 3 months after intervention. The intervention sessions will be held once weekly lasting 90 minutes for 8 weeks.

The investigators primarily hypothesize that participants in the mindfulness-based intervention group will improve depressive symptom after 8 weeks compared with the control group. Secondary, the mindfulness-based intervention will improve anxiety, stress, cognitive functions, sleep quality, quality of life and mindfulness ability.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Jingxia Lin, PhD
  • Phone Number: 852-39176311
  • Email: jxlin@hku.hk

Study Locations

      • Hong Kong, Hong Kong
        • Recruiting
        • Queen Mary Hospital
        • Contact:
          • Jingxia Lin, PhD
          • Phone Number: 852-39176311
          • Email: jxlin@hku.hk

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Females aged from 18 and above
  • The Edinburgh Postnatal Depression Scale cut-off score of >=9
  • At least 6 weeks, and up to one and half years after childbirth
  • Cantonese-speaking Chinese

Exclusion Criteria:

  • Severe physical illness (myocardial infarction, hypertension, fracture, spinal problems in which yoga may be contraindicated), and seizure disorders.
  • Comorbid substance dependence
  • Women with psychotic depression, severe eating disorders, actively suicidal or obsessive-compulsive disorders
  • Known pregnancy
  • A history of bipolar disorder, schizophrenia, brain trauma or organic brain disease, mental retardation, or antisocial personality disorder
  • Practice of mindfulness (in forms of Tai Chi, Qi gong or yoga etc.) more than twice a week during the previous three months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mindfulness-based intervention
The MBI-p-R was developed in line with the model of Mindfulness-based Stress Reducation (MBSR) proposed by Kabat-Zinn. It will be conducted for 1.5 hours for each session, once a week for 8 weeks. There are four key operational components to be included in each session: engagement and introduction, mindfulness practices, daily life application, and consolidation of learning.
Active Comparator: Booklet-based psychoeducation group
The participants in the control group will be provided a booklet at baseline, including general information in handling every day stress by a new mother, as well as a record for their weekly activities. The contents covered a range of topics including work-stress, balanced diet, physical exercise, sleeping quality, bonding with baby and the treatment for depression. The participants will be contacted by phone call and/or whatsapp weekly for a short talk based on the record and content on the booklet. They will also be asked to record their daily life weekly for discussion.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline Depression at 8 weeks
Time Frame: Change from baseline to 8 weeks
The Edinburgh Postnatal Depression Scale, total score 0-30, higher scores mean worse outcome.
Change from baseline to 8 weeks
Change from 8 weeks Depression at 3 months
Time Frame: Change from 8 weeks to 3 months
The Edinburgh Postnatal Depression Scale, total score 0-30, higher scores mean worse outcome.
Change from 8 weeks to 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline Anxiety at 8 weeks
Time Frame: Change from baseline to 8 weeks
Depression Anxiety Stress Scale, Anxiety subscore 0-42, higher scores mean worse outcome.
Change from baseline to 8 weeks
Change from 8 weeks Anxiety at 3 months
Time Frame: Change from 8 weeks to 3 months
Depression Anxiety Stress Scale, Anxiety subscore 0-42, higher scores mean worse outcome.
Change from 8 weeks to 3 months
Change from Baseline Stress at 8 weeks
Time Frame: Change from baseline to 8 weeks
Depression Anxiety Stress Scale, Stress subscore 0-42, higher scores mean worse outcome.
Change from baseline to 8 weeks
Change from 8 weeks Stress at 3 months
Time Frame: Change from 8 weeks to 3 months
Depression Anxiety Stress Scale, Stress subscore 0-42, higher scores mean worse outcome.
Change from 8 weeks to 3 months
Change from Baseline Executive Function at 8 weeks
Time Frame: Change from baseline to 8 weeks
Trial Making Test, reaction time is recorded, shorter time means better outcome.
Change from baseline to 8 weeks
Change from 8 weeks Executive Function at 3 months
Time Frame: Change from 8 weeks to 3 months
Trial Making Test, reaction time is recorded, shorter time means better outcome.
Change from 8 weeks to 3 months
Change from Baseline Attention at 8 weeks
Time Frame: Change from baseline to 8 weeks
Letter Cancellation Test, correct rate and time are recorded, higher correct rate and shorter time mean better outcome.
Change from baseline to 8 weeks
Change from 8 weeks Attention at 3 months
Time Frame: Change from 8 weeks to 3 months
Letter Cancellation Test, correct rate and time are recorded, higher correct rate and shorter time mean better outcome.
Change from 8 weeks to 3 months
Change from Baseline Working Memory at 8 weeks
Time Frame: Change from baseline to 8 weeks
Digit-Span Test, minimum 0, maximum 14, higher scores mean better outcome.
Change from baseline to 8 weeks
Change from 8 weeks Working Memory at 3 months
Time Frame: Change from 8 weeks to 3 months
Digit-Span Test, minimum 0, maximum 14, higher scores mean better outcome.
Change from 8 weeks to 3 months
Change from Baseline Visual-Motor Coordination at 8 weeks
Time Frame: Change from baseline to 8 weeks
Digit-Symbol-Coding Test, minimum 0, maximum 133, higher scores mean better outcome.
Change from baseline to 8 weeks
Change from 8 weeks Visual-Motor Coordination at 3 months
Time Frame: Change from 8 weeks to 3 months
Digit-Symbol-Coding Test, minimum 0, maximum 133, higher scores mean better outcome.
Change from 8 weeks to 3 months
Change from Baseline Role Functioning at 8 weeks
Time Frame: Change from baseline to 8 weeks
Role Functioning Scale, minimum 4, maximum 38, higher scores mean better outcome.
Change from baseline to 8 weeks
Change from 8 weeks Role Functioning at 3 months
Time Frame: Change from 8 weeks to 3 months
Role Functioning Scale, minimum 4, maximum 38, higher scores mean better outcome.
Change from 8 weeks to 3 months
Change from Baseline Quality of Life at 8 weeks
Time Frame: Change from baseline to 8 weeks
The Short Form Health Survey, minimum score 0, and maximum score 100, higher scores mean better outcome.
Change from baseline to 8 weeks
Change from 8 weeks Quality of Life at 3 months
Time Frame: Change from 8 weeks to 3 months
The Short Form Health Survey, minimum score 0, and maximum score 100, higher scores mean better outcome.
Change from 8 weeks to 3 months
Change from Baseline Sleep Quality at 8 weeks
Time Frame: Change from baseline to 8 weeks
Pittsburg Sleep Quality Index, minimum 0, maximum 21, higher scores mean worse outcome.
Change from baseline to 8 weeks
Change from 8 weeks Sleep Quality at 3 months
Time Frame: Change from 8 weeks to 3 months
Pittsburg Sleep Quality Index, minimum 0, maximum 21, higher scores mean worse outcome.
Change from 8 weeks to 3 months
Change from Baseline Mindfulness Levels at 8 weeks
Time Frame: Change from baseline to 8 weeks
The Five Facet Mindfulness Questionnaire-Revised, minimum 39, maximum 195, higher scores mean better outcome.
Change from baseline to 8 weeks
Change from 8 weeks Mindfulness Levels at 3 months
Time Frame: Change from 8 weeks to 3 months
The Five Facet Mindfulness Questionnaire-Revised, minimum 39, maximum 195, higher scores mean better outcome.
Change from 8 weeks to 3 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total attendant classes during the 8-week interventions
Time Frame: At 8 weeks
The number of classes the participants attended during the 8-week period will be recorded
At 8 weeks
Self-practice time
Time Frame: At 8 weeks
How much time the participants spend for self-practice at home will be recorded
At 8 weeks
Self-practice time
Time Frame: At 3 months
How much time the participants spend for self-practice at home will be recorded
At 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jingxia Lin, PhD, The University of Hong Kong

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2019

Primary Completion (Anticipated)

July 1, 2020

Study Completion (Anticipated)

September 1, 2021

Study Registration Dates

First Submitted

March 2, 2020

First Submitted That Met QC Criteria

March 30, 2020

First Posted (Actual)

April 2, 2020

Study Record Updates

Last Update Posted (Actual)

April 2, 2020

Last Update Submitted That Met QC Criteria

March 30, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The study protocol, statistical analysis plan and clinical study report will be shared through email.

IPD Sharing Time Frame

Within one year after the completion of the study.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postnatal Depression

Clinical Trials on Mindfulness-based program (MBI-p-R)

3
Subscribe